Drugs / glyceryl nitrate
glyceryl nitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00121901 | Oct 2004 → Oct 2007 | pancreatitis | Hvidovre University Hospital | Completed | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glyceryl nitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00121901 ↗ |
| Known as | Discotrine | “INTERVENTION: The active drug was transdermal GN (Discotrine/Minitran, 3M Pharma) 15 mg/24 hours; placebo (PL) was an identical-looking patch applied before ERCP.” PMID 19410035 ↗ May 2009 |
| Known as | glyceryl trinitrate | “Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.” NCT00121901 ↗ |
| Known as | GTN | “Sublingual glyceryl trinitrate (GTN) has been shown to produce periampullary sphincter relaxation.” PMID 11531863 ↗ Sep 2001 |
| Known as | Minitran | “INTERVENTION: The active drug was transdermal GN (Discotrine/Minitran, 3M Pharma) 15 mg/24 hours; placebo (PL) was an identical-looking patch applied before ERCP.” PMID 19410035 ↗ May 2009 |